# Pentoxifylline Role Against Chemotherapy-induced Neuropathy

> **NCT06562998** · NA · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 72 (actual)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT06562998
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06562998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06562998, "Pentoxifylline Role Against Chemotherapy-induced Neuropathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06562998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*